. Author manuscript; available in PMC: 2021 Sep 21.

Published in final edited form as: Mult Scler. 2020 Sep 10;27(8):1175–1186. doi: 10.1177/1352458520951046

Table 3:

Comparison of clinical and radiological factors of MOG-IgG1+ with and without NMDA-R-IgG

Variable	MOG-IgG1+, NMDA-R-IgG- (N=33)	MOG-IgG1+, NMDA-R-IgG+ (N=11)	Total (N=44)	p value
Sex				1.000¹
Male	14 (42.4%)	5 (45.5%)	19 (43.2%)
Female	19 (57.6%)	6 (54.5%)	25 (56.8%)
Age				0.284²
Median	27.4	18.0	22.2
IQR	10.6, 50.7	13.0, 30.0	11.1, 40.6
MRI brain leptomeningeal enhancement				0.045¹
Absent	27 (81.8%)	5 (45.5%)	32 (72.7%)
Present	6 (18.2%)	6 (54.5%)	12 (27.3%)
Transverse myelitis				0.489¹
Absent	13 (39.4%)	6 (54.5%)	19 (43.2%)
Present	20 (60.6%)	5 (45.5%)	25 (56.8%)
Optic neuritis				0.169¹
Absent	10 (30.3%)	6 (54.5%)	16 (36.4%)
Present	23 (69.7%)	5 (45.5%)	28 (63.6%)
Encephalopathy				0.001¹
Absent	22 (66.7%)	1 (9.1%)	23 (52.3%)
Present	11 (33.3%)	10 (90.9%)	21 (47.7%)
Seizures				0.045¹
Absent	27 (81.8%)	5 (45.5%)	32 (72.7%)
Present	6 (18.2%)	6 (54.5%)	12 (27.3%)

^1.

Fisher’s Exact Test for Count Data

^2.

Wilcoxun Rank rank sum test